Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.44 - $18.55 $444,630 - $663,014
35,742 Added 117.38%
66,192 $1.11 Million
Q1 2024

May 15, 2024

SELL
$10.63 - $13.68 $942,870 - $1.21 Million
-88,699 Reduced 74.44%
30,450 $393,000
Q4 2023

Feb 14, 2024

BUY
$9.59 - $12.91 $1.14 Million - $1.54 Million
119,149 New
119,149 $1.38 Million
Q2 2023

Aug 14, 2023

SELL
$12.92 - $15.89 $516,748 - $635,536
-39,996 Reduced 79.56%
10,274 $140,000
Q1 2023

May 15, 2023

SELL
$13.67 - $16.37 $1.5 Million - $1.8 Million
-109,764 Reduced 68.59%
50,270 $770,000
Q4 2022

Feb 14, 2023

BUY
$12.05 - $15.14 $1.07 Million - $1.35 Million
88,939 Added 125.1%
160,034 $2.15 Million
Q3 2022

Nov 14, 2022

BUY
$12.82 - $20.22 $409,881 - $646,473
31,972 Added 81.72%
71,095 $945,000
Q2 2022

Aug 15, 2022

SELL
$17.89 - $20.47 $1.09 Million - $1.25 Million
-61,075 Reduced 60.95%
39,123 $749,000
Q1 2022

May 16, 2022

SELL
$18.39 - $21.85 $368,737 - $438,114
-20,051 Reduced 16.67%
100,198 $2 Million
Q4 2021

Feb 14, 2022

SELL
$18.96 - $22.76 $414,010 - $496,987
-21,836 Reduced 15.37%
120,249 $2.46 Million
Q3 2021

Nov 15, 2021

BUY
$20.59 - $30.01 $698,186 - $1.02 Million
33,909 Added 31.35%
142,085 $3.06 Million
Q2 2021

Aug 16, 2021

BUY
$24.15 - $30.08 $253,405 - $315,629
10,493 Added 10.74%
108,176 $3.12 Million
Q1 2021

May 17, 2021

SELL
$19.71 - $25.23 $127,267 - $162,910
-6,457 Reduced 6.2%
97,683 $2.38 Million
Q4 2020

Feb 16, 2021

BUY
$16.44 - $20.2 $787,591 - $967,721
47,907 Added 85.19%
104,140 $2.02 Million
Q3 2020

Nov 16, 2020

BUY
$17.36 - $26.36 $801,285 - $1.22 Million
46,157 Added 458.09%
56,233 $978,000
Q2 2020

Aug 14, 2020

SELL
$22.31 - $28.29 $1.5 Million - $1.9 Million
-67,208 Reduced 86.96%
10,076 $264,000
Q1 2020

May 15, 2020

SELL
$17.75 - $27.72 $1.18 Million - $1.85 Million
-66,715 Reduced 46.33%
77,284 $1.87 Million
Q4 2019

Feb 14, 2020

BUY
$21.0 - $24.83 $1.87 Million - $2.21 Million
89,074 Added 162.17%
143,999 $3.58 Million
Q3 2019

Nov 14, 2019

SELL
$20.34 - $32.66 $840,997 - $1.35 Million
-41,347 Reduced 42.95%
54,925 $1.17 Million
Q2 2019

Aug 14, 2019

SELL
$28.03 - $36.85 $1.51 Million - $1.99 Million
-54,018 Reduced 35.94%
96,272 $3.06 Million
Q1 2019

May 15, 2019

BUY
$28.71 - $33.65 $1.14 Million - $1.33 Million
39,540 Added 35.7%
150,290 $0
Q4 2018

Feb 14, 2019

BUY
$31.18 - $44.64 $716,360 - $1.03 Million
22,975 Added 26.17%
110,750 $3.56 Million
Q3 2018

Nov 13, 2018

BUY
$42.3 - $53.5 $3.06 Million - $3.87 Million
72,406 Added 471.12%
87,775 $0
Q2 2018

Aug 10, 2018

BUY
$38.7 - $48.1 $169,119 - $210,197
4,370 Added 39.73%
15,369 $0
Q1 2018

May 11, 2018

BUY
$32.2 - $40.45 $72,578 - $91,174
2,254 Added 25.77%
10,999 $437,000
Q4 2017

Feb 09, 2018

BUY
$32.65 - $37.9 $285,524 - $331,435
8,745
8,745 $293,000

Others Institutions Holding PAHC

About PHIBRO ANIMAL HEALTH CORP


  • Ticker PAHC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,337,600
  • Market Cap $440M
  • Description
  • Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...
More about PAHC
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.